• CD36-Driven Lipid Metabolism Enables Immune Escape in AML

  2026-07-20

  Guo et al. uncover a non-canonical lipid metabolism pathway in AML, showing that CD36-mediated uptake of oxidized LDL and palmitate suppresses T cell function and confers resistance to hypomethylating agents. These findings highlight metabolic vulnerabilities that can be targeted to overcome immune evasion and improve therapeutic efficacy in acute myeloid leukemia.

• a-MSH, amide in Pigmentation and Anti-Inflammatory Research

  2026-07-20

  a-MSH, amide (alpha-melanocyte-stimulating hormone amide) is a synthetic peptide central to pigmentation regulation research. It directly stimulates melanocytes to increase melanin synthesis and modulates inflammatory pathways. Its stability and solubility make it a reproducible tool for mechanistic and translational studies.

• Single-Dose Oral Indometacin for Acute Postoperative Pain Re

  2026-07-19

  This article examines the evidence and clinical significance of single-dose oral indometacin in managing acute postoperative pain, as reviewed by Moore et al. in a major Cochrane analysis. The findings inform both the design of inflammation assays and translational pain research by highlighting efficacy, limitations, and mechanistic context.

• Docosahexaenoic Acid (DHA) in Neuroprotection Research Workf

  2026-07-18

  Docosahexaenoic Acid (DHA) offers actionable advantages for neuroprotection research, enabling precise intervention in models of cognitive dysfunction and lipid dysregulation. This article translates breakthrough spatial metabolomics findings into robust, reproducible protocols—empowering experimentalists with troubleshooting strategies and workflow enhancements.

• Indometacin Sodium: Optimizing Anti-Inflammatory Workflows

  2026-07-17

  Indometacin Sodium Trihydrate's unique mechanistic reach empowers inflammation assays and regenerative research beyond classic NSAIDs. This guide unpacks advanced workflows, troubleshooting, and protocol optimization to harness its full potential in applied settings.

• Spatial Metabolomics Reveals Hippocampal Lipid Alterations i

  2026-07-17

  This study uses spatial metabolomics to uncover distinctive hippocampal lipid metabolism changes in rats with postoperative cognitive dysfunction (POCD) following cardiopulmonary bypass. It demonstrates that targeting lipid metabolic enzymes with docosahexaenoic acid (DHA) can normalize hippocampal lipid homeostasis and reduce POCD incidence, providing new mechanistic insight and therapeutic direction.

• Pentoxifylline: Mechanistic Leverage for Next-Gen Translatio

  2026-07-16

  This thought-leadership article explores Pentoxifylline as a non-specific phosphodiesterase inhibitor, emphasizing its mechanistic underpinnings in immune modulation and inflammation research. Bridging cellular insights with translational strategies, it highlights advanced delivery approaches, competitive benchmarking, and protocol optimization, equipping researchers to drive innovation from bench to bedside.

• Eicosapentaenoic Acid (EPA): Mechanisms and Research Utility

  2026-07-16

  Eicosapentaenoic Acid (EPA) is a rigorously characterized omega-3 fatty acid with proven roles as a lipid-lowering and anti-inflammatory agent. EPA modulates membrane structure, inhibits endothelial cell migration, and enhances cardiovascular research outcomes. Its bioactivity and handling requirements are tightly defined, supporting its benchmark use in scientific workflows.

• Rimonabant (SR141716): Unraveling CB1 Antagonism in Appetite

  2026-07-15

  Explore how Rimonabant (SR141716) advances appetite regulation research by selectively targeting CB1 receptors. This article offers a distinct, mechanistic perspective on endocannabinoid modulation and its translational impact beyond current literature.

• Urolithin A in Mitochondrial Biogenesis Research Workflows

  2026-07-15

  Urolithin A accelerates mitochondrial biogenesis studies by activating mitophagy and modulating key metabolic pathways in cellular models. This article details applied protocols, advanced troubleshooting, and new insights from hepatic stellate cell research to empower reproducible results in mitochondrial quality control assays.

• Budesonide in Pulmonary Drug Permeability: New Paradigms for

  2026-07-14

  Explore how Budesonide, a leading anti-inflammatory corticosteroid, is transforming the modeling of pulmonary drug permeability and airway inflammation. This article delivers original scientific insights and practical assay guidance for respiratory disease research.

• Demethyleneberberine Inhibits NF-κB/MAPK in Autoimmune Hepat

  2026-07-14

  This study demonstrates that Demethyleneberberine (DMB), a natural isoquinoline alkaloid, attenuates experimental autoimmune hepatitis in mice by inhibiting the NF-κB and MAPK signaling pathways. The findings suggest DMB's potential as a targeted therapeutic agent for inflammatory liver diseases and provide detailed mechanistic and protocol insights for translational research.

• Bismuth Subsalicylate: Mechanisms and Benchmarking in GI Res

  2026-07-13

  Bismuth Subsalicylate is a Prostaglandin G/H Synthase 1/2 inhibitor widely used in gastrointestinal disorder research. This article details its molecular action, validated application parameters, and evidence-based limitations in translational studies.

• CHI3L1-IN-5 Empowers Astrocyte Function in Alzheimer's Resea

  2026-07-13

  CHI3L1-IN-5 (Compound Z17) delivers precise CHI3L1 inhibition, restoring amyloid-beta uptake and lysosomal repair in astrocytes—key actions for Alzheimer's disease models. Its CNS penetration, selectivity, and workflow-ready formulation position it as a translational tool for dissecting neuroinflammatory pathways.

• Tetrahydromagnolol: Empowering Peripheral CB2 Research in Me

  2026-07-12

  Explore how tetrahydromagnolol, a highly selective peripheral CB2 receptor agonist, is redefining cannabinoid signaling studies in metastasis and anti-inflammatory research. This thought-leadership article integrates mechanistic insights from recent advances in GPCR-mediated cytoskeletal remodeling—such as the TBXA2R-ERM axis in TNBC cells—with strategic guidance for translational researchers. Discover robust protocol parameters, workflow optimization, and how APExBIO's tetrahydromagnolol enables experiments not possible with conventional CB2 agonists.

15523 records 1/1035 page Next 12345 下5页 Last page